• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adjusted estimates for time-to-event endpoints.事件发生时间终点的校正估计值。
Lifetime Data Anal. 2008 Dec;14(4):484-95. doi: 10.1007/s10985-008-9098-9. Epub 2008 Sep 15.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.竞争风险分析应报告所有病因特异性危害和累积发生率函数的结果。
J Clin Epidemiol. 2013 Jun;66(6):648-53. doi: 10.1016/j.jclinepi.2012.09.017. Epub 2013 Feb 14.
4
Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.利用历史数据促进肿瘤学开发项目:2 个 2 期贝叶斯增强控制试验设计案例研究。
Pharm Stat. 2020 May;19(3):276-290. doi: 10.1002/pst.1990. Epub 2020 Jan 5.
5
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.白消安暴露与儿童及青年造血细胞移植后的生存及毒性的关联:一项多中心回顾性队列分析
Lancet Haematol. 2016 Nov;3(11):e526-e536. doi: 10.1016/S2352-3026(16)30114-4. Epub 2016 Oct 13.
6
Bayesian optimal phase II clinical trial design with time-to-event endpoint.贝叶斯最优设计的Ⅱ期临床试验设计,以时间为终点事件。
Pharm Stat. 2020 Nov;19(6):776-786. doi: 10.1002/pst.2030. Epub 2020 Jun 10.
7
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?受限平均生存时间:协变量调整能否提高随机临床试验的精度?
Clin Trials. 2018 Apr;15(2):178-188. doi: 10.1177/1740774518759281. Epub 2018 Mar 4.
8
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.儿童急性淋巴细胞白血病的干细胞移植:比较同胞供体与匹配的无关供体的前瞻性国际多中心试验——ALL-SCT-BFM-2003 试验。
J Clin Oncol. 2015 Apr 10;33(11):1265-74. doi: 10.1200/JCO.2014.58.9747. Epub 2015 Mar 9.
9
Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards.非比例风险情况下基于相对时间概念的具有生存时间结局的 II 期临床试验的随机截尾检验。
J Biopharm Stat. 2024 Jul 3;34(4):596-611. doi: 10.1080/10543406.2023.2244056. Epub 2023 Aug 14.
10
An adaptive group sequential phase II design to compare treatments for survival endpoints in rare patient entities.一种用于比较罕见患者群体生存终点治疗方法的适应性组序贯II期设计。
J Biopharm Stat. 2012;22(2):294-311. doi: 10.1080/10543406.2010.531831.

引用本文的文献

1
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.异基因造血细胞移植联合非清髓性预处理治疗血液系统恶性肿瘤:二十多年来的改善结果。
Haematologica. 2021 Jun 1;106(6):1599-1607. doi: 10.3324/haematol.2020.248187.
2
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.异基因造血细胞移植后的生存、非复发死亡率和复发相关死亡率:2003-2007 年队列与 2013-2017 年队列比较。
Ann Intern Med. 2020 Feb 18;172(4):229-239. doi: 10.7326/M19-2936. Epub 2020 Jan 21.
3
Estimation of the adjusted cause-specific cumulative probability using flexible regression models for the cause-specific hazards.使用针对特定原因的危险的灵活回归模型估计调整后的特定原因累积概率。
Stat Med. 2019 Sep 10;38(20):3896-3910. doi: 10.1002/sim.8209. Epub 2019 Jun 18.
4
Gluten Intake and Risk of Celiac Disease: Long-Term Follow-up of an At-Risk Birth Cohort. gluten 摄入与乳糜泻风险:高危出生队列的长期随访。
Am J Gastroenterol. 2019 Aug;114(8):1307-1314. doi: 10.14309/ajg.0000000000000255.
5
Higher Mortality in Men Compared with Women following Distal Radius Fracture in Population Aged 50 Years or Above: Are Common Distal Radius Fracture Classifications Useful in Predicting Mortality?50 岁及以上人群桡骨远端骨折后男性死亡率高于女性:常见桡骨远端骨折分类在预测死亡率方面是否有用?
Biomed Res Int. 2019 Jan 23;2019:5359204. doi: 10.1155/2019/5359204. eCollection 2019.
6
Measuring skin necrosis in a randomised controlled feasibility trial of heat preconditioning on wound healing after reconstructive breast surgery: study protocol and statistical analysis plan for the PREHEAT trial.在一项关于热预处理对乳房重建术后伤口愈合影响的随机对照可行性试验中测量皮肤坏死情况:PREHEAT试验的研究方案和统计分析计划
Pilot Feasibility Stud. 2018 Jan 17;4:34. doi: 10.1186/s40814-017-0223-y. eCollection 2018.
7
Cord-Blood Transplantation in Patients with Minimal Residual Disease.微小残留病患者的脐血移植
N Engl J Med. 2016 Sep 8;375(10):944-53. doi: 10.1056/NEJMoa1602074.
8
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.默克尔细胞癌的辅助放疗和化疗:来自国家癌症数据库的6908例病例的生存分析
J Natl Cancer Inst. 2016 May 31;108(9). doi: 10.1093/jnci/djw042. Print 2016 Sep.
9
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.基于高剂量CD20靶向放射免疫疗法的自体移植可改善持续性套细胞淋巴瘤的预后。
Br J Haematol. 2015 Dec;171(5):788-97. doi: 10.1111/bjh.13773. Epub 2015 Oct 12.
10
An ensemble survival model for estimating relative residual longevity following stroke: Application to mortality data in the chronic dialysis population.一种用于估计中风后相对剩余寿命的综合生存模型:在慢性透析人群死亡率数据中的应用。
Stat Methods Med Res. 2017 Dec;26(6):2667-2680. doi: 10.1177/0962280215605107. Epub 2015 Sep 24.

本文引用的文献

1
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.采用非清髓性或清髓性预处理方案进行异基因造血细胞移植治疗淋巴瘤和慢性淋巴细胞白血病后的疗效。
Blood. 2008 Jan 1;111(1):446-52. doi: 10.1182/blood-2007-07-098483. Epub 2007 Oct 4.
2
A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.一个用于基于分层Cox回归模型估计直接调整生存曲线的SAS宏。
Comput Methods Programs Biomed. 2007 Nov;88(2):95-101. doi: 10.1016/j.cmpb.2007.07.010. Epub 2007 Sep 11.
3
Corrected group prognostic curves and summary statistics.校正组预后曲线及汇总统计数据。
J Chronic Dis. 1982;35(8):669-74. doi: 10.1016/0021-9681(82)90019-4.
4
Adjusted survival curve estimation using covariates.使用协变量进行调整后的生存曲线估计。
J Chronic Dis. 1982;35(6):437-43. doi: 10.1016/0021-9681(82)90058-3.
5
Covariance analysis of censored survival data.删失生存数据的协方差分析
Biometrics. 1974 Mar;30(1):89-99.

事件发生时间终点的校正估计值。

Adjusted estimates for time-to-event endpoints.

作者信息

Storer Barry E, Gooley Ted A, Jones Michael P

机构信息

Fred Hutchinson Cancer Research Center, Seattle, USA.

出版信息

Lifetime Data Anal. 2008 Dec;14(4):484-95. doi: 10.1007/s10985-008-9098-9. Epub 2008 Sep 15.

DOI:10.1007/s10985-008-9098-9
PMID:18791867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2660858/
Abstract

In the analysis of retrospective data or when interpreting results from a single-arm phase II clinical trial relative to historical data, it is often of interest to show plots summarizing time-to-event outcomes comparing treatment groups. If the groups being compared are imbalanced with respect to factors known to influence outcome, these plots can be misleading and seemingly incompatible with results obtained from a regression model that accounts for these imbalances. We consider ways in which covariate information can be used to obtain adjusted curves for time-to-event outcomes. We first review a common model-based method and then suggest another model-based approach that is not as reliant on model assumptions. Finally, an approach that is partially model free is suggested. Each method is applied to an example from hematopoietic cell transplantation.

摘要

在回顾性数据分析中,或者在解释单臂II期临床试验相对于历史数据的结果时,展示总结治疗组事件发生时间结局的图表通常很有意义。如果所比较的组在已知会影响结局的因素方面不均衡,这些图表可能会产生误导,并且看似与考虑了这些不均衡因素的回归模型所得到的结果不一致。我们考虑了利用协变量信息来获得事件发生时间结局的调整曲线的方法。我们首先回顾一种常见的基于模型的方法,然后提出另一种基于模型的方法,该方法对模型假设的依赖程度较低。最后,提出了一种部分无模型的方法。每种方法都应用于造血细胞移植的一个实例。